Both are administered as subcutaneous injections, typically once daily
This guide breaks down the clinical differences, the trial data, who belongs on each protocol, and how BHRC approaches GLP-1 prescribing in 2026
After the item has been shipped, you can demand a return, refund or item exchange in accordance with the Gmarkets Return and Exchange policies below
In metabolic diseases such as diabetes, co-delivery systems integrating GLP-1RAs with complementary agents such as DPP-4 inhibitors or insulin have demonstrated superior long-term glycemic control compared to monotherapies
Ontario Drug Benefit Formulary - Semaglutide ODB coverage criteria for Ozempic and Rybelsus (type 2 diabetes)
Byetta was an intermediate step to Ozempic